Curaleaf Reports Record First Quarter 2021 Financial and Operational Results Record First Quarter 2021 Revenue(1) of $260 Million, up 170% YoY and up 13% Sequentially Record First Quarter 2021 Adjusted EBITDA(1) of $63 Million, up 213% YoY and Up 16% Sequentially, Achieving a Margin of 24% Revenue Guidance for the Second Quarter 2021 of $305 million to $315 million News provided by Share this article Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021. All financial information is provided in U.S. dollars unless otherwise indicated. 1Q 2021 Financial Highlights (Unaudited)